Insider Transactions in Q1 2022 at 2seventy Bio, Inc. (TSVT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
368,857
+39.84%
|
$4,426,284
$12.2 P/Share
|
|
Mar 01
2022
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,750
+26.98%
|
-
|
|
Mar 01
2022
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,500
+30.32%
|
-
|
|
Mar 01
2022
|
Nicola Heffron Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+30.27%
|
-
|
|
Mar 01
2022
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
133,500
+16.2%
|
-
|
|
Feb 17
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
427
-0.74%
|
$5,978
$14.78 P/Share
|
|
Feb 07
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,636
-2.87%
|
$26,176
$16.01 P/Share
|
|
Feb 04
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
467
-0.81%
|
$7,005
$15.41 P/Share
|
|
Jan 07
2022
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
3,270
-1.71%
|
$75,210
$23.91 P/Share
|
|
Jan 07
2022
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,452
-2.3%
|
$33,396
$23.91 P/Share
|
|
Jan 07
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
896
-1.52%
|
$20,608
$23.91 P/Share
|